Abstract:
The author presents the results of studying the influence of the preventive treatment by the levels of soluble forms of vascular cell adhesion molecule-1 (s-VCAM-1) and platelet endothelial cell adhesion moleculae-1 (s-PECAM-1) in 47 patients with gestational endotheliopathy (GE), 18 healthy pregnant controls by using an enzyme-linked immunosorbent assay (ELISA).